We are live on ! Find out more
QF

QVT Financial Portfolio holdings

AUM $1.37B
1-Year Est. Return 148.1%
This Fund
S&P 500
This Quarter Est. Return
+10.8%
1 Year Est. Return
+148.1%
3 Year Est. Return
+280.64%
5 Year Est. Return
+413.55%
10 Year Est. Return
+2,213.36%
AUM
$1.71B
AUM Growth
+$237M
Cap. Flow
-$219M
Cap. Flow %
-12.82%
Top 10 Hldgs %
41.11%
Holding
90
New
18
Increased
12
Reduced
23
Closed
12

Sector Composition

Rank Sector Weight
1 Healthcare 22.76%
2 Financials 13.07%
3 Energy 7.75%
4 Real Estate 3.46%
5 Consumer Discretionary 2.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
26
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$21.2M 1.25%
+115,000
New +$20.4M
ARWR icon
27
Arrowhead Research
ARWR
$12.1B
$21.1M 1.24%
+2,047,782
New +$16.4M
BRFS
28
DELISTED
BRF SA
BRFS
$20.8M 1.22%
997,220
PHH
29
DELISTED
PHH Corporation
PHH
$20.6M 1.21%
844,655
-74,700
-8% -$1.79M
ANAC
30
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$20.5M 1.2%
1,222,503
-135,800
-10% -$1.88M
DYAX
31
DELISTED
DYAX CORPORATION
DYAX
$19.9M 1.17%
2,640,900
+250,000
+10% +$1.9M
STNG icon
32
Scorpio Tankers
STNG
$3.96B
$18.1M 1.06%
153,728
-174,080
-53% -$19.5M
MDVN
33
DELISTED
MEDIVATION, INC.
MDVN
$15.5M 0.91%
487,056
-123,200
-20% -$3.72M
PCYC
34
DELISTED
PHARMACYCLICS INC
PCYC
$14.7M 0.86%
139,021
-205,300
-60% -$24.9M
ETFC
35
DELISTED
E*Trade Financial Corporation
ETFC
$14.7M 0.86%
748,418
-268,100
-26% -$4.77M
ASPS icon
36
PUT
Altisource Portfolio Solutions
ASPS
$65.4M
$14.3M 0.84%
11,288
+8,163
+261% +$9.85M
TSM icon
37
PUT
TSMC
TSM
$2.09T
$13.3M 0.78%
761,300
ARRY
38
DELISTED
Array Biopharma Inc
ARRY
$13.2M 0.77%
2,633,600
-245,000
-9% -$1.33M
CYTR
39
DELISTED
CytRx Corp
CYTR
$13M 0.76%
+345,917
New +$6.3M
ARMH
40
PUT
DELISTED
ARM HOLDINGS PLC ADS
ARMH
$12M 0.71%
220,100
KERX
41
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$11.1M 0.65%
854,000
-58,000
-6% -$693K
NRF
42
DELISTED
NorthStar Realty Finance Corp.
NRF
$10.8M 0.63%
+407,401
New +$8.23M
OLED icon
43
PUT
Universal Display
OLED
$3.71B
$10.3M 0.6%
300,000
CASC
44
DELISTED
Cascadian Therapeutics, Inc.
CASC
$10M 0.59%
950,383
+306,700
+48% +$3.43M
INFI
45
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$9.96M 0.58%
720,947
-605,663
-46% -$8.55M
OCRX
46
DELISTED
Ocera Therapeutics, Inc.
OCRX
$8.64M 0.51%
728,827
+633,357
+663% +$5.92M
MRTX
47
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$8.24M 0.48%
540,978
-52,000
-9% -$889K
RPRX
48
DELISTED
Repros Therapeutics Inc.
RPRX
$7.81M 0.46%
440,091
+138,257
+46% +$2.61M
GDOT icon
49
CALL
Green Dot
GDOT
$753M
$7.61M 0.45%
+302,600
New +$7.05M
XNCR icon
50
Xencor
XNCR
$1.44B
$7.31M 0.43%
+800,000
New +$6.86M

Similar funds

QVT Financial's Q4 2013 Portfolio in Review

As of Q4 2013, QVT Financial held 90 positions worth $1.71B, up 16% from $1.47B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

QVT Financial withdrew a net $219M in Q4 2013, closing 12 positions and reducing 23 holdings. Its most notable exit was Madrigal Pharmaceuticals, an estimated $11M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Financials and Energy.

Against the trend, QVT Financial opened a new position in LL Flooring Holdings, Inc. worth $28.5M.

  • QVT Financial's largest Q4 2013 buy was LL Flooring Holdings, Inc.: 276,900 shares worth $28.5M.
  • QVT Financial added most to Onity Group in Q4 2013, an estimated $37.3M increase.
  • QVT Financial's biggest Q4 2013 reduction was PHARMACYCLICS INC, cutting an estimated $24.9M.
  • QVT Financial fully exited Madrigal Pharmaceuticals in Q4 2013, selling an estimated $11M.
  • QVT Financial's ten largest holdings make up 41% of its $1.71B portfolio in Q4 2013.
  • QVT Financial opened 18 new positions and closed 12 in Q4 2013.
  • QVT Financial's portfolio value rose 16% quarter-over-quarter to $1.71B.

Based on QVT Financial's 13F filing for Q4 2013, filed 18 Feb 2014.